# Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy

> **NCT03382743** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Kasr El Aini Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Pain Uterus

## Interventions

- **DRUG:** Endocervical Lidocaine spray

## Key facts

- **NCT ID:** NCT03382743
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-20
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2018-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03382743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03382743, "Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03382743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*